N-(Azetidin-3-yl)-2,2,2-trifluoroacetamide hydrochloride, 97%, 100mg

Imidazo[1,2-b]pyridazin-3-amine, 95.0%, 10g

2-methyl-2-(3-methyl-4-nitrophenoxy)propanoic acid, 95.0%, 1g

(4-Chloro-3-methyl-phenoxy)-acetic acid, 95.0%, 1g

tert-Butyl (E)-(2-(bromomethyl)-3-fluoroallyl)carbamate, 95%, 100mg

Analytical and precision scale Entris® II series Models with external adjustment, not certified, 0.1 g, 8200 g, BCE8201-1S

1-(4-Cyanopyridin-2-yl)piperidine-4-carboxylic acid, 250mg

7-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98+%, 250mg

N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine, 95.0%, 5g

Methyl 6-methoxypyrimidine-4-carboxylate, 98%, 500mg

Diethyl 2-cyclobutylidenemalonate, 95%, 1g

1-CYCLOPENTYL-1H-PYRAZOL-4-AMINE HCL, 95.0%, 250mg

2-Morpholinoacetamide, 97%, 100mg